Baird Melissa's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Jan 23, 2025
- Accession no.
- 0001773751-25-000021
- Filed
- Jan 23, 2025, 4:32 PM ET
- Trade date
- Jan 21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.99M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baird MelissaCIK 0001837815 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | Class A Common Stock | MOption exerciseAcquired | +67,687 | $0.40 | +$27,074.8 | 774,559 | Direct | |
| Jan 21, 2025 | Class A Common Stock | SSaleDisposed | −4,195 | $28.57F2 | −$119,862.48 | 770,364 | Direct | |
| Jan 21, 2025 | Class A Common Stock | SSaleDisposed | −13,430 | $29.58F3 | −$397,278.2 | 756,934 | Direct | |
| Jan 21, 2025 | Class A Common Stock | SSaleDisposed | −9,280 | $28.67F4 | −$266,023.26 | 747,654 | Direct | |
| Jan 21, 2025 | Class A Common Stock | SSaleDisposed | −31,845 | $29.55F5 | −$940,956.06 | 715,809 | Direct | |
| Jan 21, 2025 | Class A Common Stock | SSaleDisposed | −4,461 | $29.05F6 | −$129,595.17 | 711,348 | Direct | |
| Jan 21, 2025 | Class A Common Stock | SSaleDisposed | −4,476 | $29.72F7 | −$133,015.53 | 706,872 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | Class A Common Stock | MOption exerciseDisposed | −67,687 | $0.00 | $0 | 189,930 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.025 - $28.995. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.00 - $29.95. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.20- $28.975. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.00 - $29.96. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $28.545 - $29.445. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.515- $29.94. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.